The number of people with susceptibility test result for rifampicin in Zambia
Zambia: The number of people with susceptibility test result for rifampicin was 85.35 in 2021. ▲ Rising
Latest (2021)
85.35
Change on year
down 5.9%
World rank
84th
of 146 countries
All-time high
98.26
in 2018
All-time low
2.83
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Zambia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Zambia stood at 85.35.
The figure is down 5.9% on the previous year and up 2,914.6% over five years.
That places Zambia 84th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Zambia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 2.83 | — |
| 2018 | 98.26 | +3370.6% |
| 2019 | 96.56 | -1.7% |
| 2020 | 90.66 | -6.1% |
| 2021 | 85.35 | -5.9% |
Zambia compared with similar countries
- Zambia's 85.35 is above the median for lower middle income countries, which is 78.77, 1.1× the median. (32 countries reporting)
- Zambia's 85.35 is above the median for Sub-Saharan Africa, which is 61.16, 1.4× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 65.88 | 2.83 | 98.26 | 3 |
| 2020s | 88.01 | 85.35 | 90.66 | 2 |
Countries ranked near Zambia
More health data for Zambia
- Un projection of annual infant deaths, annual growth rate -1.09 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 809.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,894 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 1.68 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0743 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.69 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Zambia?
- The number of people with susceptibility test result for rifampicin in Zambia was 85.35 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Zambia?
- The highest recorded value was 98.26 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Zambia?
- The lowest recorded value was 2.83 in 2017.
- How does Zambia rank for the number of people with susceptibility test result for rifampicin?
- Zambia ranks 84th out of 146 countries with data for 2021.
- Where does this Zambia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).